Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS · Unclassified
Ask the data
Instant answers about Aarey Drugs & Pharmaceuticals Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY09† | FY10† | FY11† | FY12† | FY13† | FY14† | FY15† | FY16† | FY17† | FY18† | FY19† | FY20† | FY21† | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.5 | 46.6 | 65.9 | 131.2 | 172.6 | 201.3 | 216.0 | 249.2 | 398.4 | 349.4 | 354.8 | 300.1 | 332.9 | 492.7 | 62.5 | 395.6 | 473.9 | 472.3 |
| EBITDA | — | — | — | — | — | — | — | — | — | 7.6 | 7.9 | 3.2 | 4.6 | 11.3 | 1.5 | 4.5 | 2.2 | 7.2 |
| Operating margin | — | — | — | — | — | — | — | — | — | 2.2% | 2.2% | 1.1% | 1.4% | 2.3% | 2.4% | 1.1% | 0.5% | 1.5% |
| Interest | — | — | — | — | — | — | — | — | — | 1.9 | 2.2 | 1.8 | 2.4 | 2.0 | 0.6 | 4.4 | 4.0 | 5.0 |
| Depreciation | — | — | — | — | — | — | — | — | — | 0.7 | 1.0 | 0.9 | 0.9 | 2.0 | 0.7 | 1.7 | 1.9 | 2.9 |
| Profit before tax | 1.1 | 1.2 | 1.0 | 0.4 | 0.9 | 1.4 | 1.4 | 1.8 | 8.0 | 8.2 | 9.0 | 7.2 | 8.3 | 10.0 | 0.8 | 5.3 | 6.1 | 5.4 |
| Tax | 0.2 | 0.0 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.5 | 2.1 | 2.0 | 2.4 | 1.4 | 2.0 | 2.5 | 0.2 | 0.7 | 2.1 | 1.4 |
| Net profit | 0.9 | 1.1 | 0.8 | 0.3 | 0.7 | 1.1 | 1.1 | 1.3 | 5.9 | 6.2 | 6.5 | 5.8 | 6.3 | 7.5 | 0.5 | 4.7 | 4.0 | 4.0 |
| EPS ₹ | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.72 | 0.19 | 1.84 | 3.27 | 1.39 |
| Operating cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | 18.6 | -39.1 | 7.9 | 9.7 | 10.1 |
| Capex | — | — | — | — | — | — | — | — | — | — | — | — | — | -2.2 | 1.0 | 0.0 | 0.0 | 12.4 |
| Dividend paid | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 291.3 | 305.0 | 238.3 | 297.2 |
| Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 117.4 | 132.8 | 138.5 | 150.4 |
Quarterly performance
last 76 quarters · ₹ crore| SEP '07† | DEC '07† | MAR '08† | JUN '08† | SEP '08† | DEC '08† | MAR '09† | JUN '09† | SEP '09† | DEC '09† | MAR '10† | JUN '10† | SEP '10† | DEC '10† | MAR '11† | JUN '11† | SEP '11† | DEC '11† | MAR '12† | JUN '12† | SEP '12† | DEC '12† | MAR '13† | JUN '13† | SEP '13† | DEC '13† | MAR '14† | JUN '14† | SEP '14† | DEC '14† | MAR '15† | JUN '15† | SEP '15† | DEC '15† | MAR '16† | JUN '16† | SEP '16† | DEC '16† | MAR '17† | JUN '17† | SEP '17† | DEC '17† | MAR '18† | JUN '18† | SEP '18† | DEC '18† | MAR '19† | JUN '19† | SEP '19† | DEC '19† | MAR '20† | JUN '20† | SEP '20† | DEC '20† | MAR '21† | JUN '21 | SEP '21 | DEC '21 | MAR '22 | JUN '22 | SEP '22 | DEC '22 | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.1 | 8.5 | 8.9 | 7.0 | 6.0 | 8.3 | 6.3 | 7.0 | 7.0 | 12.1 | 20.6 | 9.6 | 13.1 | 15.3 | 27.9 | 28.1 | 31.5 | 32.4 | 39.2 | 34.6 | 40.5 | 48.3 | 49.3 | 47.3 | 57.5 | 58.4 | 38.0 | 34.6 | 49.0 | 52.8 | 79.6 | 42.6 | 33.2 | 64.5 | 108.9 | 95.4 | 83.2 | 96.9 | 122.9 | 73.8 | 69.2 | 89.6 | 116.8 | 67.4 | 71.6 | 78.4 | 137.3 | 66.2 | 63.6 | 59.6 | 110.7 | 25.2 | 49.8 | 79.7 | 178.2 | 97.5 | 134.7 | 140.3 | 120.2 | 117.3 | 76.3 | 62.5 | 158.2 | 51.0 | 57.8 | 76.5 | 210.3 | 126.9 | 105.1 | 133.8 | 108.1 | 102.2 | 84.2 | 96.4 | 189.5 | 44.6 |
| Operating profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.9 | 1.5 | 1.9 | 2.2 | 2.0 | 1.2 | 2.2 | 2.0 | 2.5 | 1.3 | 1.1 | 1.3 | -0.5 | 1.5 | 0.3 | 0.5 | 2.4 | 2.9 | 3.4 | 3.1 | 1.9 | -0.6 | 4.3 | 1.5 | -2.2 | 1.3 | 1.9 | 2.7 | -1.4 | 1.2 | 3.7 | 2.2 | -4.8 | 1.7 | 2.6 | -1.5 | 4.3 | 1.3 |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.2% | 2.0% | 2.7% | 2.5% | 1.7% | 1.8% | 3.1% | 2.5% | 1.8% | 1.9% | 1.8% | 2.2% | -0.4% | 6.0% | 0.6% | 0.6% | 1.3% | 3.0% | 2.5% | 2.2% | 1.5% | -0.5% | 5.6% | 2.4% | -1.4% | 2.6% | 3.2% | 3.5% | -0.7% | 0.9% | 3.5% | 1.6% | -4.5% | 1.7% | 3.1% | -1.6% | 2.3% | 3.0% |
| Other income | — | — | — | — | — | — | — | — | — | 0.0 | 0.1 | — | 0.1 | — | 0.1 | 0.2 | — | — | -0.1 | — | 0.1 | 0.0 | 0.2 | 0.3 | 0.1 | 0.1 | 1.0 | 0.0 | 0.1 | 0.1 | 2.4 | 0.7 | 1.0 | 1.1 | 0.3 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.2 | 0.3 | 1.7 | 1.2 | 0.5 | 0.7 | 1.8 | 1.5 | 0.9 | 0.8 | 3.4 | 0.7 | 2.5 | 2.1 | 1.6 | 0.7 | 0.8 | 0.1 | 1.1 | 2.4 | -0.9 | 0.5 | 5.5 | 0.7 | 0.8 | 0.3 | 5.1 | 1.6 | 0.0 | 0.7 | 7.5 | 1.6 | 0.8 | 4.2 | -0.4 | 1.7 |
| Interest | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.0 | 0.3 | 0.3 | 0.6 | 0.6 | 0.2 | 0.4 | 1.0 | 0.7 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.8 | 0.6 | 0.6 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 1.0 | 0.9 | 1.3 | 1.1 | 1.1 | 1.0 | 1.5 | 0.9 | 2.5 | 1.0 | 1.3 | 0.9 | 1.8 | 1.7 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.4 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.5 | 0.2 | 0.3 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.6 | 0.2 | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | -1.4 | 0.5 | 0.7 | 0.8 | 0.8 | 0.8 |
| Profit before tax | 0.1 | 0.4 | 0.4 | 0.2 | 0.2 | 0.3 | 0.4 | 0.2 | 0.2 | 0.3 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 | 0.2 | -0.5 | 0.4 | 0.5 | 0.3 | -0.3 | 0.2 | 1.0 | 0.2 | -0.1 | 0.6 | 0.3 | 0.1 | 0.4 | 0.6 | 0.5 | 0.2 | 0.6 | 1.1 | 1.7 | 1.8 | 3.4 | 1.9 | 1.6 | 1.8 | 2.8 | 2.1 | 2.1 | 1.6 | 3.2 | 2.1 | 1.3 | 1.4 | 2.4 | 1.6 | 1.9 | 1.7 | 3.2 | 2.7 | 3.1 | 2.2 | 2.0 | 0.8 | 2.3 | 0.8 | 2.6 | 0.7 | 1.0 | 1.5 | 2.1 | 1.3 | 1.8 | 1.4 | 1.6 | 1.7 | 1.5 | 0.9 | 1.3 | 0.5 |
| Tax | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 | 0.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 2.4 | 0.0 | 0.0 | 0.0 | 1.4 | 0.2 | 0.0 | 0.0 | 1.8 | 0.2 | 0.3 | 0.2 | 1.8 | 0.0 | -0.2 | 0.2 | 1.3 | 0.0 | 0.2 | 0.4 | -0.0 | 0.1 | 0.1 | 0.7 | 1.1 | 0.4 | 0.5 | -0.3 | -0.3 | -0.5 |
| Net profit | 0.1 | 0.4 | 0.3 | 0.2 | 0.2 | 0.3 | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.1 | 0.2 | 0.2 | 0.4 | 0.1 | 0.2 | -0.5 | 0.4 | 0.5 | 0.3 | -0.5 | 0.2 | 0.8 | 0.2 | -0.2 | 0.6 | 0.3 | 0.1 | 0.1 | 0.6 | 0.5 | 0.2 | 0.0 | 1.1 | 1.7 | 1.8 | 1.3 | 1.9 | 1.6 | 1.8 | 0.8 | 2.1 | 2.1 | 1.6 | 0.7 | 2.1 | 1.3 | 1.4 | 1.0 | 1.4 | 1.9 | 1.7 | 1.4 | 2.5 | 2.8 | 1.9 | 0.2 | 0.8 | 2.5 | 0.5 | 1.4 | 0.7 | 0.8 | 1.0 | 2.1 | 1.2 | 1.6 | 0.7 | 0.5 | 1.4 | 1.0 | 1.3 | 1.6 | 1.0 |
| EPS ₹ | 0.30 | 0.72 | 0.56 | 0.47 | 0.41 | 0.64 | 0.29 | 0.50 | 0.42 | 0.54 | 0.85 | 0.72 | 0.15 | 0.40 | 0.39 | 0.78 | 0.16 | 0.51 | -0.33 | 0.30 | 0.29 | 0.17 | -0.32 | 0.15 | 0.48 | 0.15 | -0.15 | 0.34 | 0.16 | 0.09 | 0.05 | 0.36 | 0.27 | 0.12 | 0.02 | 0.65 | 0.96 | 1.00 | 0.74 | 1.05 | 0.82 | 0.90 | 0.35 | 0.90 | 0.92 | 0.66 | 0.31 | 0.90 | 0.55 | 0.60 | 0.43 | 0.58 | 0.79 | 0.73 | 0.60 | 1.07 | 1.22 | 0.77 | 0.30 | 0.32 | 0.83 | 0.19 | 0.14 | 0.29 | 0.31 | 0.40 | 0.77 | 0.88 | 1.14 | 0.26 | 0.04 | 0.48 | 0.72 | 0.20 | 0.55 | 0.36 |
| Revenue YoY | — | — | — | — | 45.9% | -2.5% | -29.6% | 0.6% | 15.6% | 46.2% | 227.2% | 37.1% | 89.1% | 26.3% | 35.6% | 193.3% | 140.0% | 111.4% | 40.7% | 23.0% | 28.3% | 49.1% | 25.7% | 36.9% | 42.2% | 21.1% | -22.8% | -26.8% | -14.9% | -9.6% | 109.2% | 23.0% | -32.2% | 22.0% | 36.9% | 123.9% | 150.5% | 50.3% | 12.9% | -22.6% | -16.9% | -7.5% | -5.0% | -8.7% | 3.6% | -12.4% | 17.5% | -1.7% | -11.3% | -24.0% | -19.4% | -61.9% | -21.6% | 33.5% | 61.0% | 286.7% | 170.3% | 76.1% | -32.5% | 20.3% | -43.4% | -55.5% | 31.5% | -56.6% | -24.2% | 22.4% | 33.0% | 149.0% | 81.8% | 74.9% | -48.6% | -19.5% | -20.0% | -27.9% | 75.3% | -56.3% |
| Profit YoY | — | — | — | — | 33.3% | -11.1% | -46.4% | 8.7% | 5.0% | -15.6% | 180.0% | 44.0% | -61.9% | -25.9% | -54.8% | 8.3% | 0.0% | 25.0% | -342.1% | 7.7% | 525.0% | 16.0% | — | -42.9% | 62.0% | -13.8% | — | 141.7% | -66.7% | -40.0% | — | 3.4% | 66.7% | 33.3% | -50.0% | 83.3% | 273.3% | 780.0% | 3250.0% | 73.6% | -1.8% | 2.3% | -38.8% | 9.9% | 30.3% | -13.9% | -9.8% | 0.0% | -39.5% | -9.7% | 35.1% | -35.2% | 42.3% | 21.4% | 41.0% | 84.6% | 53.5% | 14.7% | -83.7% | -68.1% | -10.9% | -74.9% | 487.0% | -10.0% | -69.2% | 108.2% | 59.3% | 72.2% | 105.1% | -29.4% | -78.1% | 10.5% | -36.3% | 77.8% | 231.9% | -25.5% |
Returns & margins
trailing-twelve-month, per quarter| JUN '08 | SEP '08 | DEC '08 | MAR '09 | JUN '09 | SEP '09 | DEC '09 | MAR '10 | JUN '10 | SEP '10 | DEC '10 | MAR '11 | JUN '11 | SEP '11 | DEC '11 | MAR '12 | JUN '12 | SEP '12 | DEC '12 | MAR '13 | JUN '13 | SEP '13 | DEC '13 | MAR '14 | JUN '14 | SEP '14 | DEC '14 | MAR '15 | JUN '15 | SEP '15 | DEC '15 | MAR '16 | JUN '16 | SEP '16 | DEC '16 | MAR '17 | JUN '17 | SEP '17 | DEC '17 | MAR '18 | JUN '18 | SEP '18 | DEC '18 | MAR '19 | JUN '19 | SEP '19 | DEC '19 | MAR '20 | JUN '20 | SEP '20 | DEC '20 | MAR '21 | JUN '21 | SEP '21 | DEC '21 | MAR '22 | JUN '22 | SEP '22 | DEC '22 | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.7% | 3.5% | 4.4% | 4.3% | 2.8% | 3.3% | 3.5% | 3.9% | 4.4% | 4.2% | 2.9% | 3.0% | 2.4% | 2.8% | 3.5% | 3.2% |
| ROCE | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 6.8% | 5.9% | 6.0% | 6.2% | 5.8% | 6.4% | 5.9% | 6.3% | 6.5% | 6.4% | 6.9% | 7.2% | 6.0% | 5.7% | 5.2% | 4.9% |
| Net margin | 3.6% | 3.5% | 3.4% | 3.3% | 3.3% | 3.3% | 2.7% | 2.5% | 2.6% | 2.0% | 1.8% | 1.3% | 1.0% | 0.8% | 0.8% | 0.2% | 0.2% | 0.5% | 0.5% | 0.4% | 0.3% | 0.4% | 0.4% | 0.5% | 0.7% | 0.5% | 0.4% | 0.5% | 0.5% | 0.6% | 0.6% | 0.5% | 0.6% | 0.9% | 1.2% | 1.5% | 1.8% | 1.8% | 1.9% | 1.8% | 1.9% | 2.0% | 2.0% | 1.8% | 1.8% | 1.6% | 1.7% | 1.9% | 2.0% | 2.3% | 2.2% | 1.9% | 1.8% | 1.7% | 1.6% | 1.5% | 1.1% | 1.2% | 1.1% | 1.2% | 1.5% | 1.0% | 1.1% | 1.2% | 1.1% | 1.2% | 1.0% | 0.9% | 0.9% | 0.8% | 1.1% | 1.1% | 1.2% |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.7% | 2.2% | 2.1% | 2.2% | 2.2% | 2.2% | 2.2% | 2.0% | 1.9% | 1.1% | 1.3% | 1.1% | 0.7% | 1.4% | 1.5% | 1.9% | 2.1% | 2.3% | 1.5% | 1.9% | 1.9% | 0.7% | 1.4% | 0.8% | 1.1% | 1.1% | 0.9% | 1.2% | 1.0% | 0.5% | 0.6% | 0.4% | -0.5% | 1.5% | 1.6% |
| Debt / equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.21 | 0.21 | 0.32 | 0.32 | 0.31 | 0.31 | 0.24 | 0.24 | 0.29 | 0.29 | 0.25 | 0.25 | 0.34 | 0.34 | 0.33 | 0.33 |
| Interest coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.89 | 5.36 | 5.82 | 5.83 | 4.94 | 5.03 | 4.62 | 4.23 | 4.91 | 5.14 | 4.72 | 4.39 | 4.36 | 4.40 | 4.88 | 5.77 | 6.28 | 5.60 | 4.58 | 4.26 | 3.38 | 3.27 | 3.00 | 2.32 | 2.38 | 2.22 | 2.34 | 2.43 | 2.47 | 2.04 | 2.10 | 2.10 | 2.01 | 2.08 | 1.75 |
| Asset turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.99 | 1.65 | 1.42 | 1.19 | 1.41 | 1.47 | 1.30 | 1.55 | 1.89 | 2.10 | 1.99 | 1.89 | 1.46 | 1.33 | 1.59 | 1.40 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '22 | MAR '23 | SEP '23 | MAR '24 | SEP '24 | MAR '25 | SEP '25 | MAR '26 | |
|---|---|---|---|---|---|---|---|---|
| Share capital | 25.4 | 25.4 | 25.4 | 28.1 | 28.1 | 28.1 | 28.4 | 28.4 |
| Other equity / reserves | 91.2 | 92.0 | 93.5 | 104.7 | 107.5 | 110.4 | 120.4 | 122.0 |
| Total equity | 116.6 | 117.4 | 118.9 | 132.8 | 135.6 | 138.5 | 148.8 | 150.4 |
| Borrowings | 24.2 | 37.7 | 37.4 | 31.4 | 38.6 | 34.9 | 50.8 | 50.0 |
| Current liabilities | 89.5 | 168.1 | 109.8 | 168.2 | 0.5 | 96.9 | 142.8 | 145.1 |
| Non-current liabilities | 22.4 | 5.8 | 5.2 | 4.0 | 138.4 | 2.9 | 2.3 | 1.8 |
| Total assets | 228.4 | 291.3 | 234.0 | 305.0 | 274.5 | 238.3 | 294.0 | 297.2 |
| Property, plant & equipment | 14.3 | 13.9 | 13.2 | 14.7 | 13.0 | 16.2 | 25.1 | 25.8 |
| Capital work-in-progress | — | 0.0 | 0.0 | — | 0.0 | 0.0 | — | 0.0 |
| Investments | 0.4 | 0.0 | 109.5 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 |
| Inventories | 20.5 | 28.8 | 22.4 | 34.7 | 29.8 | 45.5 | 39.1 | 41.5 |
| Receivables | 132.8 | 189.8 | 0.0 | 184.5 | 142.4 | 129.6 | 122.3 | 129.7 |
| Cash & equivalents | 0.1 | 0.7 | 1.2 | 1.6 | 1.5 | 1.5 | 7.2 | 1.4 |
Cash flow
annual · ₹ crore · line = free cash flow| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Cash from operations | 18.6 | -39.1 | 7.9 | 9.7 | 10.1 |
| Cash from investing | 24.4 | 11.2 | -7.3 | -5.9 | -12.4 |
| Cash from financing | 4.4 | -22.5 | 4.1 | -3.8 | 2.2 |
| Capex | -2.2 | 1.0 | 0.0 | 0.0 | 12.4 |
| Free cash flow | 20.8 | -40.1 | 7.9 | 9.7 | -2.3 |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Aarey Drugs & Pharmaceuticals Limited | 307 | 107.72 | 62.8 | 2.04 | 3.2% |
StoxGud checklist: Neutral setup · 6/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Aarey Drugs & Pharmaceuticals Limited?
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) closed at ₹107.72 on NSE on 06 Nov 2026.
What is the market cap of Aarey Drugs & Pharmaceuticals Limited?
₹307 crore at the latest close.
What is the P/E ratio of Aarey Drugs & Pharmaceuticals Limited?
62.8, on trailing-twelve-month earnings from its filings.
How fast is Aarey Drugs & Pharmaceuticals Limited growing?
Aarey Drugs & Pharmaceuticals Limited: revenue has compounded at 96.3% a year over three years; net profit at 100.8% a year. Latest-quarter revenue is down 56.3% year on year, profit down 25.5%.
How profitable is Aarey Drugs & Pharmaceuticals Limited?
On a trailing-twelve-month basis return on equity is 3.2%, return on capital employed 4.9%, operating margin 1.6%, net margin 1.2%.
How much debt does Aarey Drugs & Pharmaceuticals Limited have?
Aarey Drugs & Pharmaceuticals Limited is lightly geared: debt to equity is 0.33 with borrowings of ₹50 cr against cash of ₹1 cr (balance sheet of 2026-03-31). Operating profit covers interest 1.7 times.
Financials parsed from Aarey Drugs & Pharmaceuticals Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from SEP '07, annual from FY09, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). † = the company's standalone results as published on BSE, used for quarters before JUN '21 (full years marked † are summed from them); cross-checked against the NSE filings where both exist. Information only, not investment advice.